维普期刊资源整合服务平台（V6.5）

121篇 您的检索式：作者名="McCubrey JA"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	The raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia 显示文摘	Lee JTJr McCubrey JA	2002	Leukemia2002，16，4：	1
2	Roles of the Raf/MEK/ERKpathway in cell growth,malignant transformation and drug resistance显示文摘	McCubrey JA Steelman LS Chappell WH		0，，08：	1
3	Targeting survival cas- cades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/ Akt/ mTOR and Jak/STAT pathways for effective leukemia therapy 显示文摘	McCubrey JA Steelnmn LS Abrams SL	2008	Leukemia2008，22，4：	1
4	Current treatment strate- gies for inhibiting mTOR in cancer显示文摘	Chiarini F Evangelisti C McCubrey JA	2015	Trends Pharmacol Sci2015，36，2：	1
5	The role ofdownstream signaling pathways of the epidermal growth fac-tor receptor for Artesunate's activity in cancer cells显示文摘	Konkimalla VB McCubrey JA Efferth T	2009	Curr Cancer Drug Targets2009，9，：	1
6	The Raf/Mek/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia显示文摘	Lee JT McCubrey JA	2002	Leukemia2002，16，：	1
7	Redox regulation of the calcium/calmodulin-dependent protein kinases显示文摘	Howe C J LaHair MM McCubrey JA	2004	J Biol Chem2004，279，44：	1
8	Roles of the Raf/MEK /ERK pathway in cell growth,malignant transformation and drug resistance显示文摘	McCubrey JA Steelman LS Chappell WH	2007	Biochim Biophys Acta2007，1773，8：	1
9	A Dominant Role for p53-de-pen- dent cellular senescence in radiosensitization of human prostate cancer cells显示文摘	Lehmann BD McCubrey JA	2007	Cell Cycle2007，6，5：	1
10	Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance 显示文摘	McCubrey JA Abrams SL Ligresti G	2008	Leukemia2008，22，11：	1
11	Pancreatic cancer stem ceils: Association with cell surface markers, prognosis, resistance, metastasis and treatment显示文摘	Fitzgerald TL McCubrey JA	2014	Adv Biol Regul2014，56，：	1
12	Interactions be- tween the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cells显示文摘	McCubrey JA Lee JT Steelman LS	2001	Cancer Detect Prev2001，25，：	1
13	Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance显示文摘	McCubrey JA Steelman LS Chappell WH	2007	Biochim Biophys Acta2007，1773，8：	1
14	Muhifaceted Roles of GSK-3 and Wnt/beta-catenin in Hematopoiesis and Leukemogene- sis : Opportunities for Therapeutic Intervention 显示文摘	McCubrey JA Steelman LS Bertrand F E	2014	Leukemia2014，28，1：	1
15	Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lym- phokine- dependent cell lines显示文摘	Buttke TM McCubrey JA Owen TC	1993	J Immunol Methods1993，157，12：	1
16	Emerging Raf In- hibitors显示文摘	McCubrey JA Steelman LS Abrams SL	2009	Exp Opin Emerging Drugs2009，14，4：	1
17	GSK-3 as potential target for therapeutic intervention in cancer显示文摘	Mccubrey JA Steelman LS Bertrand FE Davis NM Sokolosky M Abrams SL	2014	Oncotarget2014，5，10：	1
18	Suppression of apoptosis: role in cell growth and neoplasia 显示文摘	White MK McCubrey JA	2001	Leukemia2001，15，7：	1
19	Modulation of Raf/MEK/ERK kinase activity does not affect the chemoresistance profile of advanced prostate cancer cells 显示文摘	Lee JT Steelman LS McCubrey JA	2005	Int J Oncol2005，26，6：	1
20	Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways 显示文摘	McCubrey JA Steelman LS Kempf CR	2011	J Cell Physiol2011，226，11：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示